共 55 条
Photocatalytic degradation of ibuprofen using TiO2 sensitized by Ru(II) polyaza complexes
被引:22
作者:
Gongora, J. F.
[1
]
Elizondo, P.
[1
]
Hernandez-Ramirez, A.
[1
]
机构:
[1] Univ Autonoma Nuevo Leon, Fac Ciencias Quim, San Nicolas De Los Garza, NL, Mexico
关键词:
PERSONAL CARE PRODUCTS;
RUTHENIUM SENSITIZER;
DOPED TIO2;
SOLAR;
PHARMACEUTICALS;
WATER;
REMOVAL;
MECHANISM;
PPCPS;
SYSTEMS;
D O I:
10.1039/c6pp00222f
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
In this work, modification of TiO2 was carried out by incorporation of two novel Ru(II) polyaza complexes. The N-1-(2-aminobenzyliden)-N-2, N-2-bis(2-(2-aminobenzyliden) aminoethyl) ethane-1,2-diaminoruthenium(II) and N-1, N-2-bis(2-aminobenziliden) ethane-1,2-diaminoruthenium(II) complexes were synthesized via metal-ligand direct reaction. The complexes were characterized by UV-Vis, FTIR and fluorescence spectroscopy, and the chemical composition was obtained from elemental analysis by the combustion method; additionally, the sensitized TiO2 catalysts were also characterized by XRD, SEM and diffuse reflectance techniques. The photocatalytic activity of the prepared catalysts was tested in a batch reactor under visible radiation for the degradation of ibuprofen in aqueous solution. The evolution of the drug degradation process was evaluated by high-performance liquid chromatography (HPLC), while the mineralization percentage was monitored by the determination of total organic carbon (TOC). The results indicated that the incorporation of these complexes improves the activation of TiO2 under visible light, increasing the degradation and mineralization percentage of ibuprofen up to 35% compared to the unmodified material, thereby making it suitable for application in heterogeneous photocatalysis of the said pharmaceutical in aqueous media using visible light as the energy source.
引用
收藏
页码:31 / 37
页数:7
相关论文